by Kenjiro Lolling | Jan 9, 2025 | Uncategorized
Congratulations to the team at Alesta Therapeutics on raising an impressive €65 million in their Series A financing! Led by Frazier Life Sciences and Droia Ventures, this round will push their work in rare disease therapies to new levels. Their lead program, ALE1,...
by Kenjiro Lolling | Feb 10, 2023 | Uncategorized
The favorable Dutch business environment in the Greater Rotterdam-The Hague area, and specifically in Leiden, made a great impression on JCR. The central location in Europe and proximity to EMA, the high concentration of biotech and pharma in the country with major...
by Kenjiro Lolling | Feb 10, 2023 | Uncategorized
Proof-of-concept fund UNIIQ is investing 350,000 euros in Delft startup SoundCell together with DE (Delft Enterprises). The TU Delft spin-off is developing innovative technology that can measure the vibrations made by living bacteria. SoundCell’s technology has...